You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORMP Sale Disclosure
Gabay Avraham · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$330.74K
Gabay Avraham Chief Financial Officer
ORMP
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
ORMP daily price context
Close on/before transaction
$4.61
Jul 1, 2026
First close after public filing
$4.57
Jul 6, 2026
30-day return after filing
-3.94%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 73,360 shares @ $4.51
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001213900-26-075069
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$330.74K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. ORMP Current | Sale | Jul 1, 2026 | $330.74K |